Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 4/15/05  and contains information from public web pages.

Mr. Ulrich Bartke

Wrong Ulrich Bartke?
 
Background

Employment History

Education

  • Ph.D. , Pharmaceutical Chemistry
    University of Berlin
  • BSc , Pharmacy
    University of Berlin
Web References
SEC EDGAR Submission 0000950134-05-007535
www.sec.gov, 15 April 2005 [cached]
Ulrich Bartke
...
Ulrich Bartke - Vice President, Global Sales and Marketing.Mr. Bartke joined Inyx in June 2004.From November 2003 until joining Inyx, Mr. Bartke was a self-employed consultant to pharmaceutical companies.Prior to that, Mr. Bartke served as Vice President Global Sales & Marketing of PowderJect Pharmaceuticals Plc, where he directed sales growth from approximately $40 million to in excess of $290 million during his two-year tenure from 2001 to August 2003, at which time PowderJect was acquired and Mr. Bartke became a pharmaceutical industry consultant focusing on U.S. and European markets.Mr. Bartke began his professional career and served for 17 years, from 1984 to 2001, with GlaxoSmithKline ("GSK") in a number of different executive capacities.He started out in manufacturing management positions before moving into several marketing directorships at SmithKline Beecham Pharmaceuticals.In his last position with GSK, he served as Therapy Area Director, Vaccines, for GSK Pharmaceuticals Europe.Mr. Bartke holds a BSc in Pharmacy and a Ph.D. in Pharmaceutical Chemistry from the University of Berlin.
Ulrich Bartke Appointed to New Position of Vice President Global Sales & Marketing of Inyx
www.prnewswire.com, 27 May 2004 [cached]
Ulrich Bartke Appointed to New Position of Vice President Global Sales & Marketing of Inyx - Will Direct Intensified Sales Growth and Strategic Marketing Initiatives -
NEW YORK, May 27 /PRNewswire-FirstCall/ -- Inyx, Inc. (OTC Bulletin Board: IYXI), an emerging specialty pharmaceutical company with a focus on niche drug delivery technologies and products, announced today that Ulrich Bartke, Ph.D. will be joining the company on June 1, 2004 in the newly established, senior management position of Vice President Global Sales & Marketing.
...
"Initially, Mr. Bartke will focus on building Inyx's contract manufacturing revenues and increasing the utilization of production capacity, with the objective to increase sales and profitability," Dr. Kachkar informed.
...
"I am very pleased to be joining Inyx," said Mr. Bartke."Inyx has niche aerosol pharmaceutical development and production expertise that is needed in the marketplace today, particularly the proven ability to develop and produce non-ozone-depleting aerosol products.I am looking forward to assisting in the growth of Inyx's business."Mr. Bartke will be based initially at the company's development and production center located in Cheshire, England, operated under its wholly owned subsidiary INyX Pharma Limited.He will be directing the company's sales and marketing activities around the world, including in North America, Latin and South America and Asia as well as Europe.
Ulrich Bartke, Ph.D. From 2001 to 2003, Mr. Bartke served as Vice President Global Sales & Marketing of PowderJect Pharmaceuticals Plc, where he directed sales growth from approximately $40 million to in excess of $290 million during his two- year tenure.In June 2003, PowderJect, at the time a publicly owned company traded on the London Stock Exchange, was acquired by Chiron Corporation.Following this acquisition, Mr. Bartke became a consultant to the pharmaceutical industry, focusing on U.S. and European markets.Mr. Bartke began his professional career and served for 17 years, from 1984 to 2001, with GlaxoSmithKline companies in a number of different executive capacities.He started out in manufacturing management positions before moving into several marketing directorships at SmithKline Beecham Pharmaceuticals.In his last position, he served as Therapy Area Director, Vaccines, for GSK Pharmaceuticals Europe.Mr. Bartke holds a BSc in Pharmacy and a Ph.D. in Pharmaceutical Chemistry from the University of Berlin.
Cameron Associates
www.cameronassoc.com, 26 May 2004 [cached]
ULRICH BARTKE APPOINTED TO NEW POSITION OF VICE PRESIDENT GLOBAL SALES & MARKETING OF INYX
...
Home < Client News and Info < Inyx, Inc. < Press Releases < ULRICH BARTKE APPOINTED TO NEW POSITION OF VICE PRESIDENT GLOBAL SALES & MARKETING OF INYX
...
ULRICH BARTKE APPOINTED TO NEW POSITION OF VICE PRESIDENT GLOBAL SALES & MARKETING OF INYXWill Direct Intensified Sales Growth and Strategic Marketing Initiatives
NEW YORK - May 26, 2004 - Inyx, Inc. (OTC BB: IYXI), an emerging specialty pharmaceutical company with a focus on niche drug delivery technologies and products, announced today that Ulrich Bartke, Ph.D. will be joining the company on June 1, 2004 in the newly established, senior management position of Vice President Global Sales & Marketing.
...
"Initially, Mr. Bartke will focus on building Inyx's contract manufacturing revenues and increasing the utilization of production capacity, with the objective to increase sales and profitability," Dr. Kachkar informed.
...
"I am very pleased to be joining Inyx," said Mr. Bartke."Inyx has niche aerosol pharmaceutical development and production expertise that is needed in the marketplace today, particularly the proven ability to develop and produce non-ozone-depleting aerosol products.I am looking forward to assisting in the growth of Inyx's business."
Mr. Bartke will be based initially at the company's development and production center located in Cheshire, England, operated under its wholly owned subsidiary INyX Pharma Limited.He will be directing the company's sales and marketing activities around the world, including in North America, Latin and South America and Asia as well as Europe.
Ulrich Bartke, Ph.D.
From 2001 to 2003, Mr. Bartke served as Vice President Global Sales & Marketing of PowderJect Pharmaceuticals Plc, where he directed sales growth from approximately $40 million to in excess of $290 million during his two-year tenure.In June 2003, PowderJect, at the time a publicly owned company traded on the London Stock Exchange, was acquired by Chiron Corporation (Nasdaq: CHIR).Following this acquisition, Mr. Bartke became a consultant to the pharmaceutical industry, focusing on U.S. and European markets.
Mr. Bartke began his professional career and served for 17 years, from 1984 to 2001, with GlaxoSmithKline (NYSE: GSK) companies in a number of different executive capacities.He started out in manufacturing management positions before moving into several marketing directorships at SmithKline Beecham Pharmaceuticals.In his last position, he served as Therapy Area Director, Vaccines, for GSK Pharmaceuticals Europe.
Mr. Bartke holds a BSc in Pharmacy and a Ph.D. in Pharmaceutical Chemistry from the University of Berlin.
Other People with the name "Bartke":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.